Share
Other content recommended for you
- Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?
- Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
- Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
- Genetic testing in the acute setting: a round table discussion
- Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics—systematic review and meta-analysis
- Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey
- Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance
- Late-onset neonatal sepsis: recent developments
- Multidrug resistant neonatal sepsis in Peshawar, Pakistan
- Cumulative risk factors contributing to hearing loss in preterm infants